Propiedad y actividad de insiders de MaxCyte, Inc. (MXCT): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.18 |
| Capitalización | $126M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $11.7M | $25.3M | $11.2M | $15.2M | $18.8M | $47.8M | $11.1M | $46.5M | $27.9M | $20.1M |
| Inversiones a Corto | 0 | 0 | $3.2M | $1.5M | $16.0M | $207.3M | $216.3M | $121.8M | $126.6M | $83.0M |
| Cuentas por Cobrar | $2.4M | $3.2M | $4.9M | $3.2M | $5.2M | $6.9M | $11.2M | $5.8M | $4.7M | $3.5M |
| Inventario | $1.3M | $1.3M | $2.2M | $3.7M | $4.3M | $5.2M | $8.6M | $12.2M | $8.9M | $7.5M |
| Activos Corrientes | $15.8M | $30.6M | $22.4M | $24.5M | $45.3M | $270.4M | $252.3M | $190.2M | $171.7M | $118.4M |
| Inmovilizado Material | $281500 | $847600 | $1.8M | $5.5M | $6.5M | $13.4M | $33.6M | $34.8M | $30.5M | $28.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $650000 |
| Activos Totales | $16.1M | $31.4M | $24.3M | $30.0M | $51.8M | $284.1M | $286.7M | $268.3M | $239.5M | $202.5M |
| Cuentas por Pagar | $3.2M | $4.3M | $1.0M | $2.1M | $890200 | $1.8M | $292000 | $743000 | $1.4M | $1.4M |
| Deuda a Corto | 0 | $850900 | 0 | 0 | 0 | 0 | 0 | 0 | $864000 | $1.5M |
| Pasivos Corrientes | $5.7M | $7.2M | $6.6M | $9.3M | $11.6M | $15.6M | $15.4M | $17.9M | $15.8M | $14.3M |
| Deuda a Largo | $5.0M | $4.2M | $5.1M | $4.9M | $4.9M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $11.0M | $11.8M | $12.0M | $16.4M | $18.6M | $21.2M | $32.7M | $36.1M | $33.2M | $31.0M |
| Reservas | -$51.7M | -$61.6M | -$70.5M | -$83.4M | -$95.2M | -$114.3M | -$137.9M | -$175.8M | -$216.9M | -$261.5M |
| Patrimonio Neto | $5.1M | $19.6M | $12.3M | $13.6M | $33.2M | $262.9M | $254.0M | $232.2M | $206.3M | $171.5M |
| Deuda Total | $5.0M | $5.0M | $5.1M | $7.2M | $7.0M | $5.7M | $16.1M | $18.7M | $18.0M | $17.9M |
| Deuda Neta | -$6.7M | -$20.3M | -$9.4M | -$9.5M | -$27.8M | -$249.4M | -$211.2M | -$149.5M | -$136.4M | -$85.1M |
| Capital Circulante | $10.1M | $23.3M | $15.9M | $15.1M | $33.6M | $254.8M | $236.8M | $172.3M | $155.9M | $104.1M |
Salud financiera
| Deuda / Patrimonio | 0.11 |
| Ratio corriente | 12.26 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 1.43 |
Rentabilidad
| Rentabilidad sobre capital | -21.01% |
| Rentabilidad sobre capital invertido | -19.66% |
| Rentabilidad sobre activos | -19.30% |
| Margen bruto | 79.43% |
| Margen operativo | -111.63% |
| Margen neto | -114.77% |
Empresas relacionadas: ARMP · AVR · CATX · LNSR · NNOX · OWLT · PRE
Explorar sector: Healthcare · Biotechnology
Más secciones de MXCT: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones